{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:24:05Z","timestamp":1791645845686,"version":"4.3.4"},"reference-count":102,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.imlet.2011.06.007","type":"journal-article","created":{"date-parts":[[2011,7,16]],"date-time":"2011-07-16T00:11:09Z","timestamp":1310775069000},"page":"1-9","source":"Crossref","is-referenced-by-count":150,"title":["The complexity of Sj\u00f6gren's syndrome: Novel aspects on pathogenesis"],"prefix":"10.1016","volume":"141","author":[{"given":"Roland","family":"Jonsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Vogelsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Volchenkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Espinosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Wahren-Herlenius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Appel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2011.06.007_bib0005","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American\u2013European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.imlet.2011.06.007_bib0010","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/03009740310004676","article-title":"Estimating the prevalence among Caucasian women of primary Sjogren's syndrome in two general practices in Birmingham, UK","volume":"33","author":"Bowman","year":"2004","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.imlet.2011.06.007_bib0015","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/rheumatology\/kei107","article-title":"Epidemiology of primary Sjogren's syndrome in north-west Greece, 1982\u20132003","volume":"45","author":"Alamanos","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.imlet.2011.06.007_bib0020","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3109\/03009742.2010.536164","article-title":"The point prevalence of clinically relevant primary Sjogren's syndrome in two Norwegian counties","volume":"40","author":"Goransson","year":"2011","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.imlet.2011.06.007_bib0025","first-page":"378","article-title":"Risk factors for Sjogren's syndrome: a case\u2013control study","volume":"25","author":"Priori","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.imlet.2011.06.007_bib0030","series-title":"Arthritis and allied conditions \u2013 a textbook of rheumatology","first-page":"1681","article-title":"Sj\u00f6gren's syndrome","author":"Jonsson","year":"2005"},{"key":"10.1016\/j.imlet.2011.06.007_bib0035","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/rheumatology\/41.3.301","article-title":"Sjogren's syndrome in an out-patient clinic: classification of patients according to the preliminary European criteria and the proposed modified European criteria","volume":"41","author":"Brun","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.imlet.2011.06.007_bib0040","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/ard.60.5.467","article-title":"A longitudinal cohort study of Finnish patients with primary Sjogren's syndrome: clinical, immunological, and epidemiological aspects","volume":"60","author":"Pertovaara","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.imlet.2011.06.007_bib0045","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0049-0172(00)80016-5","article-title":"Clinical evolution, and morbidity and mortality of primary Sjogren's syndrome","volume":"29","author":"Skopouli","year":"2000","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.imlet.2011.06.007_bib0050","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1136\/ard.2007.074203","article-title":"Exocrine function in primary Sjogren syndrome: natural course and prognostic factors","volume":"67","author":"Haldorsen","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.imlet.2011.06.007_bib0055","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/ard.2005.041186","article-title":"Lymphoma and other malignancies in primary Sjogren's syndrome: a cohort study on cancer incidence and lymphoma predictors","volume":"65","author":"Theander","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.imlet.2011.06.007_bib0060","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/art.10221","article-title":"Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjogren's syndrome","volume":"46","author":"Ioannidis","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.imlet.2011.06.007_bib0065","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/art.20176","article-title":"Mortality and causes of death in primary Sjogren's syndrome: a prospective cohort study","volume":"50","author":"Theander","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.imlet.2011.06.007_bib0070","unstructured":"Workshop on diagnostic criteria for Sjogren's syndrome. Pisa, September 30\u2013October 1, 1988. Clin Exp Rheumatol 1989;7:111\u2013219."},{"key":"10.1016\/j.imlet.2011.06.007_bib0075","first-page":"1554","article-title":"HLA markers and clinical characteristics in Caucasians with primary Sjogren's syndrome","volume":"28","author":"Bolstad","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.imlet.2011.06.007_bib0080","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/BOR.0b013e32832f0861","article-title":"Genetics of systemic lupus erythematosus and Sjogren's syndrome","volume":"21","author":"Scofield","year":"2009","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.imlet.2011.06.007_bib0085","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1002\/art.23142","article-title":"Association of an IRF5 gene functional polymorphism with Sjogren's syndrome","volume":"56","author":"Miceli-Richard","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.imlet.2011.06.007_bib0090","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/gene.2008.94","article-title":"Additive effects of the major risk alleles of IRF5 and STAT4 in primary Sjogren's syndrome","volume":"10","author":"Nordmark","year":"2009","journal-title":"Genes Immun"},{"key":"10.1016\/j.imlet.2011.06.007_bib0095","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/gene.2008.1","article-title":"Variant form of STAT4 is associated with primary Sjogren's syndrome","volume":"9","author":"Korman","year":"2008","journal-title":"Genes Immun"},{"key":"10.1016\/j.imlet.2011.06.007_bib0100","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/gene.2010.44","article-title":"Association of EBF1, FAM167A(C8orf13)-BLK and TNFSF4 gene variants with primary Sjogren's syndrome","volume":"12","author":"Nordmark","year":"2011","journal-title":"Genes Immun"},{"key":"10.1016\/j.imlet.2011.06.007_bib0105","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/ard.2010.138966","article-title":"Potential association of muscarinic receptor 3 gene variants with primary Sjogren's syndrome","volume":"70","author":"Appel","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.imlet.2011.06.007_bib0110","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1365-3083.2005.01698.x","article-title":"Elevated serum levels of soluble E-cadherin in patients with primary Sjogren's syndrome","volume":"62","author":"Jonsson","year":"2005","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.imlet.2011.06.007_bib0115","first-page":"2044","article-title":"Serological implications of germinal center-like structures in primary Sjogren's syndrome","volume":"34","author":"Jonsson","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.imlet.2011.06.007_bib0515","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/ard.2010.144782","article-title":"Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sj\u00f6gren's syndrome","volume":"70","author":"Theander","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.imlet.2011.06.007_bib0125","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4049\/jimmunol.130.1.203","article-title":"Immunohistologic analysis of lymphoid infiltrates in primary Sjogren's syndrome using monoclonal antibodies","volume":"130","author":"Adamson","year":"1983","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2011.06.007_bib0130","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1600-0714.2008.00674.x","article-title":"Follicular dendritic cells confirm lymphoid organization in the minor salivary glands of primary Sjogren's syndrome","volume":"37","author":"Jonsson","year":"2008","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.imlet.2011.06.007_bib0135","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1002\/art.23073","volume":"56","author":"Manoussakis","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.imlet.2011.06.007_bib0140","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1749-6632.2003.tb06029.x","article-title":"Dendritic cell function in vivo during the steady state: a role in peripheral tolerance","volume":"987","author":"Steinman","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.imlet.2011.06.007_bib0145","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1146\/annurev.immunol.21.120601.141040","article-title":"Tolerogenic dendritic cells","volume":"21","author":"Steinman","year":"2003","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.imlet.2011.06.007_bib0150","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1146\/annurev.immunol.18.1.767","article-title":"Immunobiology of dendritic cells","volume":"18","author":"Banchereau","year":"2000","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.imlet.2011.06.007_bib0155","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1365-3083.2006.01811.x","article-title":"Role of dendritic cells in Sjogren's syndrome","volume":"64","author":"Vogelsang","year":"2006","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.imlet.2011.06.007_bib0160","doi-asserted-by":"crossref","first-page":"6037","DOI":"10.4049\/jimmunol.165.11.6037","article-title":"BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood","volume":"165","author":"Dzionek","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2011.06.007_bib0165","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1084\/jem.20092140","article-title":"Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens","volume":"207","author":"Jongbloed","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.imlet.2011.06.007_bib0170","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1084\/jem.20092618","article-title":"Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells","volume":"207","author":"Poulin","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.imlet.2011.06.007_bib0175","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1084\/jem.20100348","article-title":"Superior antigen cross-presentation and XCR1 expression define human CD11c+ CD141+ cells as homologues of mouse CD8+ dendritic cells","volume":"207","author":"Bachem","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.imlet.2011.06.007_bib0180","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1084\/jem.20100223","article-title":"The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8alpha+ dendritic cells","volume":"207","author":"Crozat","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.imlet.2011.06.007_bib0185","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.cytogfr.2007.10.006","article-title":"Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history","volume":"19","author":"Fitzgerald-Bocarsly","year":"2008","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.imlet.2011.06.007_bib0190","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1084\/jem.179.4.1109","article-title":"Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte\/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha","volume":"179","author":"Sallusto","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.imlet.2011.06.007_bib0195","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1126\/science.282.5388.480","article-title":"Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking","volume":"282","author":"Randolph","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.imlet.2011.06.007_bib0200","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1126\/science.1178331","article-title":"Development of monocytes, macrophages, and dendritic cells","volume":"327","author":"Geissmann","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.imlet.2011.06.007_bib0205","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/rheumatology\/kel061","article-title":"Monocyte-derived dendritic cells over-express CD86 in patients with systemic lupus erythematosus","volume":"45","author":"Decker","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.imlet.2011.06.007_bib0210","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/art.20998","article-title":"Activation of the type I interferon system in primary Sjogren's syndrome: a possible etiopathogenic mechanism","volume":"52","author":"Bave","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.imlet.2011.06.007_bib0215","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1002\/art.21006","article-title":"Gene expression profiling of minor salivary glands clearly distinguishes primary Sjogren's syndrome patients from healthy control subjects","volume":"52","author":"Hjelmervik","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.imlet.2011.06.007_bib0220","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1073\/pnas.0510837103","article-title":"Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren's syndrome","volume":"103","author":"Gottenberg","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.imlet.2011.06.007_bib0225","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1002\/eji.200738008","article-title":"Systemic increase in type I interferon activity in Sjogren's syndrome: a putative role for plasmacytoid dendritic cells","volume":"38","author":"Wildenberg","year":"2008","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.imlet.2011.06.007_bib0230","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1136\/ard.2009.118158","article-title":"Levels of plasmacytoid dendritic cells and type-2 myeloid dendritic cells are reduced in peripheral blood of patients with primary Sjogren's syndrome","volume":"69","author":"Vogelsang","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.imlet.2011.06.007_bib0235","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1038\/labinvest.3780203","article-title":"Professional antigen presenting cells in minor salivary glands in Sjogren's syndrome: potential contribution to the histopathological diagnosis?","volume":"80","author":"van Blokland","year":"2000","journal-title":"Lab Invest"},{"key":"10.1016\/j.imlet.2011.06.007_bib0240","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-3083.2010.02432.x","article-title":"Effector and regulatory T-cell subsets in autoimmunity and tissue inflammation","volume":"72","author":"Jager","year":"2010","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.imlet.2011.06.007_bib0245","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.micinf.2009.04.004","article-title":"Human Th17 cells in infection and autoimmunity","volume":"11","author":"Sallusto","year":"2009","journal-title":"Microbes Infect"},{"key":"10.1016\/j.imlet.2011.06.007_bib0250","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.4049\/jimmunol.181.4.2898","article-title":"Identification of IL-18 and Th17 cells in salivary glands of patients with Sjogren's syndrome, and amplification of IL-17-mediated secretion of inflammatory cytokines from salivary gland cells by IL-18","volume":"181","author":"Sakai","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2011.06.007_bib0255","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.2353\/ajpath.2009.090319","article-title":"Systemic and local interleukin-17 and linked cytokines associated with Sjogren's syndrome immunopathogenesis","volume":"175","author":"Katsifis","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.imlet.2011.06.007_bib0260","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/art.23214","article-title":"Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjogren's syndrome: findings in humans and mice","volume":"58","author":"Nguyen","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.imlet.2011.06.007_bib0265","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/rheumatology\/kep149","article-title":"Cytokine and autoantibody profiling related to histopathological features in primary Sjogren's syndrome","volume":"48","author":"Reksten","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.imlet.2011.06.007_bib0270","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2249.2009.03944.x","article-title":"Interleukin-17 and systemic lupus erythematosus: current concepts","volume":"157","author":"Nalbandian","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.imlet.2011.06.007_bib0275","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1006\/geno.1994.1664","article-title":"The location of a disease-associated polymorphism and genomic structure of the human 52-kDa Ro\/SSA locus (SSA1)","volume":"24","author":"Tsugu","year":"1994","journal-title":"Genomics"},{"key":"10.1016\/j.imlet.2011.06.007_bib0280","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/1529-0131(200103)44:3<638::AID-ANR112>3.0.CO;2-J","article-title":"Polymorphisms of the Ro52 gene associated with anti-Ro 52-kDa autoantibodies in patients with primary Sjogren's syndrome","volume":"44","author":"Nakken","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.imlet.2011.06.007_bib0285","first-page":"521","article-title":"A novel polymorphism of the SSA1 gene is associated with anti-SS-A\/Ro52 autoantibody in Japanese patients with primary Sjogren's syndrome","volume":"23","author":"Imanishi","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.imlet.2011.06.007_bib0290","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1084\/jem.20090585","article-title":"Loss of the lupus autoantigen Ro52\/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway","volume":"206","author":"Espinosa","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.imlet.2011.06.007_bib0295","doi-asserted-by":"crossref","first-page":"8761","DOI":"10.4049\/jimmunol.181.12.8761","article-title":"Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys","volume":"181","author":"Crispin","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2011.06.007_bib0300","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.clim.2008.01.019","article-title":"Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity","volume":"127","author":"Wong","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1016\/j.imlet.2011.06.007_bib0305","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0952-7915(00)00163-1","article-title":"Animal models of autoimmunity and their relevance to human diseases","volume":"12","author":"Sakaguchi","year":"2000","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.imlet.2011.06.007_bib0310","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1034\/j.1600-065X.2001.1820102.x","article-title":"Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance","volume":"182","author":"Sakaguchi","year":"2001","journal-title":"Immunol Rev"},{"key":"10.1016\/j.imlet.2011.06.007_bib0315","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1146\/annurev.immunol.18.1.423","article-title":"Regulatory T cells in autoimmunity*","volume":"18","author":"Shevach","year":"2000","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.imlet.2011.06.007_bib0320","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jaut.2005.01.015","article-title":"CD4 CD25high regulatory T cells are not impaired in patients with primary Sjogren's syndrome","volume":"24","author":"Gottenberg","year":"2005","journal-title":"J Autoimmun"},{"key":"10.1016\/j.imlet.2011.06.007_bib0325","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jaut.2009.10.004","article-title":"Characteristics of the minor salivary gland infiltrates in Sjogren's syndrome","volume":"34","author":"Christodoulou","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.imlet.2011.06.007_bib0330","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.2353\/ajpath.2008.080246","article-title":"Foxp3+ T-regulatory cells in Sjogren's syndrome: correlation with the grade of the autoimmune lesion and certain adverse prognostic factors","volume":"173","author":"Christodoulou","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.imlet.2011.06.007_bib0335","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1046\/j.1365-2567.2002.01417.x","article-title":"The 52,000MW Ro\/SS-A autoantigen in Sjogren's syndrome\/systemic lupus erythematosus (Ro52) is an interferon-gamma inducible tripartite motif protein associated with membrane proximal structures","volume":"106","author":"Rhodes","year":"2002","journal-title":"Immunology"},{"key":"10.1016\/j.imlet.2011.06.007_bib0340","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s10875-007-9157-0","article-title":"Interferon-alpha induces up-regulation and nuclear translocation of the Ro52 autoantigen as detected by a panel of novel Ro52-specific monoclonal antibodies","volume":"28","author":"Strandberg","year":"2008","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.imlet.2011.06.007_bib0345","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1093\/emboj\/20.9.2140","article-title":"The tripartite motif family identifies cell compartments","volume":"20","author":"Reymond","year":"2001","journal-title":"EMBO J"},{"key":"10.1016\/j.imlet.2011.06.007_bib0350","doi-asserted-by":"crossref","first-page":"33250","DOI":"10.1074\/jbc.M503066200","article-title":"Structural organization and Zn2+-dependent subdomain interactions involving autoantigenic epitopes in the Ring-B-box-coiled-coil (RBCC) region of Ro52","volume":"280","author":"Hennig","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.imlet.2011.06.007_bib0355","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.molimm.2005.04.013","article-title":"Structural, functional and immunologic characterization of folded subdomains in the Ro52 protein targeted in Sjogren's syndrome","volume":"43","author":"Ottosson","year":"2006","journal-title":"Mol Immunol"},{"key":"10.1016\/j.imlet.2011.06.007_bib0360","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.jmb.2008.01.005","article-title":"The fellowship of the RING: the RING-B-box linker region interacts with the RING in TRIM21\/Ro52, contains a native autoantigenic epitope in Sjogren syndrome, and is an integral and conserved region in TRIM proteins","volume":"377","author":"Hennig","year":"2008","journal-title":"J Mol Biol"},{"key":"10.1016\/j.imlet.2011.06.007_bib0365","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1084\/jem.182.4.983","article-title":"52-kDa SS-A\/Ro: genomic structure and identification of an alternatively spliced transcript encoding a novel leucine zipper-minus autoantigen expressed in fetal and adult heart","volume":"182","author":"Chan","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.imlet.2011.06.007_bib0370","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/art.10734","article-title":"Increased salivary gland tissue expression of Fas, Fas ligand, cytotoxic T lymphocyte-associated antigen 4, and programmed cell death 1 in primary Sjogren's syndrome","volume":"48","author":"Bolstad","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.imlet.2011.06.007_bib0375","doi-asserted-by":"crossref","first-page":"6277","DOI":"10.4049\/jimmunol.176.10.6277","article-title":"The Sjogren's syndrome-associated autoantigen Ro52 is an E3 ligase that regulates proliferation and cell death","volume":"176","author":"Espinosa","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2011.06.007_bib0380","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.bbrc.2005.11.029","article-title":"Autoantigen Ro52 is an E3 ubiquitin ligase","volume":"339","author":"Wada","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.imlet.2011.06.007_bib0385","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev.biochem.70.1.503","article-title":"Mechanisms underlying ubiquitination","volume":"70","author":"Pickart","year":"2001","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.imlet.2011.06.007_bib0390","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/35056563","article-title":"Themes and variations on ubiquitylation","volume":"2","author":"Weissman","year":"2001","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.imlet.2011.06.007_bib0395","doi-asserted-by":"crossref","first-page":"5994","DOI":"10.1128\/MCB.01630-05","article-title":"Regulation of p27 degradation and S-phase progression by Ro52 RING finger protein","volume":"26","author":"Sabile","year":"2006","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.imlet.2011.06.007_bib0400","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/j.molimm.2007.10.023","article-title":"Ro52 functionally interacts with IgG1 and regulates its quality control via the ERAD system","volume":"45","author":"Takahata","year":"2008","journal-title":"Mol Immunol"},{"key":"10.1016\/j.imlet.2011.06.007_bib0405","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/jb\/mvp127","article-title":"Ro52-mediated monoubiquitination of IKK{beta} down-regulates NF-{kappa}B signalling","volume":"146","author":"Wada","year":"2009","journal-title":"J Biochem"},{"key":"10.1016\/j.imlet.2011.06.007_bib0410","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4049\/jimmunol.179.1.26","article-title":"Cutting edge: autoantigen Ro52 is an interferon inducible E3 ligase that ubiquitinates IRF-8 and enhances cytokine expression in macrophages","volume":"179","author":"Kong","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2011.06.007_bib0415","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.4049\/jimmunol.181.3.1780","article-title":"The E3 ubiquitin ligase Ro52 negatively regulates IFN-beta production post-pathogen recognition by polyubiquitin-mediated degradation of IRF3","volume":"181","author":"Higgs","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2011.06.007_bib0420","doi-asserted-by":"crossref","first-page":"e11776","DOI":"10.1371\/journal.pone.0011776","article-title":"Self protection from anti-viral responses \u2013 Ro52 promotes degradation of the transcription factor IRF7 downstream of the viral toll-like receptors","volume":"5","author":"Higgs","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.imlet.2011.06.007_bib0425","doi-asserted-by":"crossref","first-page":"7527","DOI":"10.4049\/jimmunol.0804121","article-title":"Gene disruption study reveals a nonredundant role for TRIM21\/Ro52 in NF-kappaB-dependent cytokine expression in fibroblasts","volume":"182","author":"Yoshimi","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2011.06.007_bib0430","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1016\/j.yexcr.2008.09.011","article-title":"The autoantigen Ro52 is an E3 ligase resident in the cytoplasm but enters the nucleus upon cellular exposure to nitric oxide","volume":"314","author":"Espinosa","year":"2008","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.imlet.2011.06.007_bib0435","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/art.21571","article-title":"The type I interferon system in systemic lupus erythematosus","volume":"54","author":"Ronnblom","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.imlet.2011.06.007_bib0440","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.coi.2004.09.014","article-title":"The emerging role of interferon in human systemic lupus erythematosus","volume":"16","author":"Baechler","year":"2004","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.imlet.2011.06.007_bib0445","doi-asserted-by":"crossref","first-page":"7977","DOI":"10.1128\/JVI.02762-07","article-title":"Cellular La protein shields nonsegmented negative-strand RNA viral leader RNA from RIG-I and enhances virus growth by diverse mechanisms","volume":"82","author":"Bitko","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.imlet.2011.06.007_bib0450","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2119\/molmed.2009.00106","article-title":"RNA recognition motif (RRM) of La\/SSB: the bridge for interparticle spreading of autoimmune response to U1-RNP","volume":"16","author":"Routsias","year":"2010","journal-title":"Mol Med"},{"key":"10.1016\/j.imlet.2011.06.007_bib0455","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/1529-0131(200201)46:1<209::AID-ART10066>3.0.CO;2-1","article-title":"cell epitopes of the human La\/SSB autoantigen","volume":"46","author":"Davies","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.imlet.2011.06.007_bib0460","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1084\/jem.20081761","article-title":"Epstein\u2013Barr virus (EBV)-encoded small RNA is released from EBV-infected cells and activates signaling from toll-like receptor 3","volume":"206","author":"Iwakiri","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.imlet.2011.06.007_bib0465","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.coi.2009.05.005","article-title":"Connections between antiviral defense and autoimmunity","volume":"21","author":"Stetson","year":"2009","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.imlet.2011.06.007_bib0470","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.freeradbiomed.2004.11.001","article-title":"Modification of lupus-associated 60-kDa Ro protein with the lipid oxidation product 4-hydroxy-2-nonenal increases antigenicity and facilitates epitope spreading","volume":"38","author":"Scofield","year":"2005","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.imlet.2011.06.007_bib0475","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jaut.2010.06.020","article-title":"Pro-inflammatory role of anti-Ro\/SSA autoantibodies through the activation of furin-TACE-amphiregulin axis","volume":"35","author":"Lisi","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.imlet.2011.06.007_bib0480","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.4049\/jimmunol.174.3.1159","article-title":"Cutting edge: TLR ligands are not sufficient to break cross-tolerance to self-antigens","volume":"174","author":"Hamilton-Williams","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2011.06.007_bib0485","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1365-2249.2005.02812.x","article-title":"Cross-reaction between antibodies to the major epitope of Ro60kDa autoantigen and a homologous peptide of Coxsackie virus 2B protein","volume":"141","author":"Stathopoulou","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.imlet.2011.06.007_bib0490","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nm1167","article-title":"Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry","volume":"11","author":"McClain","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.imlet.2011.06.007_bib0495","doi-asserted-by":"crossref","first-page":"e9599","DOI":"10.1371\/journal.pone.0009599","article-title":"60kDa Ro and nRNP A frequently initiate human lupus autoimmunity","volume":"5","author":"Heinlen","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.imlet.2011.06.007_bib0500","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1365-3083.2005.01593.x","article-title":"Induction of oral tolerance in experimental Sjogren's syndrome autoimmunity","volume":"61","author":"Kurien","year":"2005","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.imlet.2011.06.007_bib0505","series-title":"Encyclopedia of life sciences (ELS)","article-title":"Sj\u00f6gren's Syndrome","author":"Jonsson","year":"2010"},{"key":"10.1016\/j.imlet.2011.06.007_bib0510","unstructured":"Vogelsang P. Dendritic cells in Sj\u00f6gren's syndrome. 2010; ISBN 978-82-308-1539-7."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247811001799?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247811001799?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T04:35:50Z","timestamp":1686198950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247811001799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":102,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0165247811001799"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2011.06.007","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}